8-K
Current Report
Viridian Therapeutics, Inc.\DE Filed Acc 0001193125-23-240931
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d533906d8k.htm…